Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 12, 2018 - Issue
Submit an article Journal homepage
62
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Fatal adverse events with molecular targeted agents in the treatment of advanced hepatocellular carcinoma: a meta-analysis of randomized controlled trials

Xiaofei Li1 Department of Infectious Diseases, Yiwu Central Hospital, Yiwu, China, [email protected]
,
Jia Wan2 The First Hospital of Nanchang, Nanchang, China
,
Zhenping Wu3 Gastroenterology Department, Jinhua Central Hospital, Jinhua, China
,
Juncai Tu1 Department of Infectious Diseases, Yiwu Central Hospital, Yiwu, China, [email protected]
,
Yongtao Hu1 Department of Infectious Diseases, Yiwu Central Hospital, Yiwu, China, [email protected]
,
Shuang Wu1 Department of Infectious Diseases, Yiwu Central Hospital, Yiwu, China, [email protected]
&
Lianqing Lou1 Department of Infectious Diseases, Yiwu Central Hospital, Yiwu, China, [email protected]Correspondence[email protected]
 show all
Pages 3043-3049 | Published online: 18 Sep 2018

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Martina Catalano, Andrea Casadei-Gardini, Gianmarco Vannini, Claudia Campani, Fabio Marra, Enrico Mini & Giandomenico Roviello. (2021) Lenvatinib: established and promising drug for the treatment of advanced hepatocellular carcinoma. Expert Review of Clinical Pharmacology 14:11, pages 1353-1365.
Read now
Wenli Qiu, Zhongqiu Wang, Rong Chen, Haibo Shi, Yanxia Ma, Hongli Zhou, Muhan Li, Wenting Li, Haibin Chen & Hongguang Zhou. (2020) Xiaoai Jiedu Recipe suppresses hepatocellular carcinogenesis through the miR‐200b-3p /Notch1 axis. Cancer Management and Research 12, pages 11121-11131.
Read now

Articles from other publishers (4)

Zheng Song, Xiujuan Chang & Yongping Yang. (2023) Management of upper gastrointestinal bleeding in advanced hepatocellular carcinoma with portal hypertension and variceal bleeding during receiving tyrosine kinase inhibitors therapy: Beyond and known frontiers. Liver Cancer International 4:3-4, pages 127-138.
Crossref
Yan Chen, Xuemei Ma, Xuefeng Zhang, Jing Luo, Linjing An, Yu Zhang, Xiujuan Chang, Zheng Dong, Wei Zhang, Huifang Kong, Jun Zhao, Huiguo Ding, Fuquan Liu & Yongping Yang. (2022) Prevention of variceal rebleeding in cirrhotic patients with advanced hepatocellular carcinoma receiving molecularly targeted therapy: a randomized pilot study of transjugular intrahepatic portosystemic shunt versus endoscopic plus β-blocker. Hepatology International 16:6, pages 1379-1389.
Crossref
Takeshi Hatanaka, Atsushi Naganuma & Satoru Kakizaki. (2021) Lenvatinib for Hepatocellular Carcinoma: A Literature Review. Pharmaceuticals 14:1, pages 36.
Crossref
Sawako Uchida-Kobayashi, Ken Kageyama, Akira Yamamoto, Hiroko Ikenaga, Kanako Yoshida, Kohei Kotani, Kenjiro Kimura, Naoshi Odagiri, Atsushi Hagihara, Hideki Fujii, Masaru Enomoto, Akihiro Tamori, Shoji Kubo, Yukio Miki & Norifumi Kawada. (2021) Lenvatinib-Induced Tumor-Related Hemorrhages in Patients with Large Hepatocellular Carcinomas. Oncology 99:3, pages 186-191.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.